Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GRASP-01-003: Trial Readiness and Endpoint Assessment in LGMD R1

NCT05618080 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT05618080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05618080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GRASP-01-003: Trial Readiness and Endpoint Assessment in LGMD R1
Lead sponsor
Virginia Commonwealth University
Phase
Observational
Overall status
Active, not recruiting
Start date
January 31, 2024
Completion date
August 31, 2028
Enrollment
100 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

calpain-3 deficiency limb girdle muscular dystrophy type 2a, lgmd2a, limb girdle muscular dystrophy, limb girdle muscular dystrophy type r1